Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

Alessandro Serretti, Alberto Chiesa, Raffaella Calati, Giampaolo Perna, Laura Bellodi, Diana De Ronchi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.

Original languageEnglish
Pages (from-to)1-18
Number of pages18
JournalInternational Clinical Psychopharmacology
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Anxiety Disorders
Mood Disorders
Demography
Drug Therapy
Therapeutics
Serotonin Plasma Membrane Transport Proteins
MEDLINE
Genes

Keywords

  • Antidepressants
  • Anxiety disorders
  • Anxiolytic drugs
  • Clinical factors
  • Genetic factors
  • Mood disorders
  • Predictors of response

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. / Serretti, Alessandro; Chiesa, Alberto; Calati, Raffaella; Perna, Giampaolo; Bellodi, Laura; De Ronchi, Diana.

In: International Clinical Psychopharmacology, Vol. 24, No. 1, 01.2009, p. 1-18.

Research output: Contribution to journalArticle

Serretti, Alessandro ; Chiesa, Alberto ; Calati, Raffaella ; Perna, Giampaolo ; Bellodi, Laura ; De Ronchi, Diana. / Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. In: International Clinical Psychopharmacology. 2009 ; Vol. 24, No. 1. pp. 1-18.
@article{9c978f79a7e24148b6481c90a955e2b2,
title = "Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders",
abstract = "The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.",
keywords = "Antidepressants, Anxiety disorders, Anxiolytic drugs, Clinical factors, Genetic factors, Mood disorders, Predictors of response",
author = "Alessandro Serretti and Alberto Chiesa and Raffaella Calati and Giampaolo Perna and Laura Bellodi and {De Ronchi}, Diana",
year = "2009",
month = "1",
doi = "10.1097/YIC.0b013e32831db2d7",
language = "English",
volume = "24",
pages = "1--18",
journal = "International Clinical Psychopharmacology",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

AU - Serretti, Alessandro

AU - Chiesa, Alberto

AU - Calati, Raffaella

AU - Perna, Giampaolo

AU - Bellodi, Laura

AU - De Ronchi, Diana

PY - 2009/1

Y1 - 2009/1

N2 - The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.

AB - The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.

KW - Antidepressants

KW - Anxiety disorders

KW - Anxiolytic drugs

KW - Clinical factors

KW - Genetic factors

KW - Mood disorders

KW - Predictors of response

UR - http://www.scopus.com/inward/record.url?scp=58349108113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349108113&partnerID=8YFLogxK

U2 - 10.1097/YIC.0b013e32831db2d7

DO - 10.1097/YIC.0b013e32831db2d7

M3 - Article

VL - 24

SP - 1

EP - 18

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

SN - 0268-1315

IS - 1

ER -